2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

L. Samuel Wann, Anne B. Curtis, Kenneth A. Ellenbogen, N. A. Mark, III Estes, Michael D. Ezekowitz, Warren M. Jackman, Craig T. January, James E. Lowe, Richard L. Page, David J. Slotwiner, William G. Stevenson, Cynthia M. Tracy, Valentin Fuster, Lars E. Ryden, David S. Cannom, Harry J. Crijns, Jonathan L. Halperin, G. Neal Kay, Jean-Yves Le Heuzey, S. Bertil OlssonEric N. Prystowsky, Juan Luis Tamargo, Alice K. Jacobs, Jeffrey L. Anderson, Nancy M. Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Judith S. Hochman, Frederick G. Kushner, Erik Magnus Ohman, Clyde W. Yancy

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E1-E8
JournalHeart Rhythm
Issue number3
Publication statusPublished - Mar 2011


  • AHA Scientific Statements
  • Focused update
  • Atrial fibrillation
  • Dabigatran
  • Antithrombotic agents

Cite this